Xu S - Search Results

1

DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.

Wang B, Huang J, Zhou J, Hui K, Xu S, Fan J, Li L, Wang X, Hsieh JT, He D, Wu K. Wang B, et al. Among authors: xu s. Cell Signal. 2016 Nov;28(11):1623-30. doi: 10.1016/j.cellsig.2016.07.011. Epub 2016 Jul 27. Cell Signal. 2016. PMID: 27476001

2

RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.

Hui K, Gao Y, Huang J, Xu S, Wang B, Zeng J, Fan J, Wang X, Yue Y, Wu S, Hsieh JT, He D, Wu K. Hui K, et al. Among authors: xu s. Cell Death Dis. 2017 Feb 9;8(2):e2600. doi: 10.1038/cddis.2017.9. Cell Death Dis. 2017. PMID: 28182001 Free PMC article.

3

[Establishment of an animal model of prostate cancer metastasis to the lung traced by AsRed2].

Liu XD, Zeng J, Xu S, Zhang T, Xie HJ, Ma ZK, Wang XY, He DL. Liu XD, et al. Among authors: xu s. Zhonghua Nan Ke Xue. 2012 Jun;18(6):504-10. Zhonghua Nan Ke Xue. 2012. PMID: 22774603 Chinese.

4

HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells.

Guan Z, Ding C, Du Y, Zhang K, Zhu JN, Zhang T, He D, Xu S, Wang X, Fan J. Guan Z, et al. Among authors: xu s. Int J Oncol. 2014 Feb;44(2):393-402. doi: 10.3892/ijo.2013.2210. Epub 2013 Dec 6. Int J Oncol. 2014. PMID: 24316875 Free PMC article.

5

Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.

Ma Z, Liu W, Zeng J, Zhou J, Guo P, Xie H, Yang Z, Zheng L, Xu S, Wang X, Chang LS, He D, Li L. Ma Z, et al. Among authors: xu s. Oncol Rep. 2015 Nov;34(5):2461-8. doi: 10.3892/or.2015.4224. Epub 2015 Aug 26. Oncol Rep. 2015. PMID: 26323996

6

Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7.

Shi Q, Gao Y, Xu S, Du C, Li F, Tang XS, Jia J, Wang X, Chang L, He D, Guo P. Shi Q, et al. Among authors: xu s. Urol Oncol. 2016 Feb;34(2):58.e11-8. doi: 10.1016/j.urolonc.2015.09.004. Epub 2015 Oct 21. Urol Oncol. 2016. PMID: 26480897

7

Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.

Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q, Xu S, Jia J, Tang X, Li F, Hui K, He D, Guo P. Gao Y, et al. Among authors: xu s. Oncotarget. 2015 Dec 22;6(41):43791-805. doi: 10.18632/oncotarget.6101. Oncotarget. 2015. PMID: 26544730 Free PMC article.

8

KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.

Du C, Gao Y, Xu S, Jia J, Huang Z, Fan J, Wang X, He D, Guo P. Du C, et al. Among authors: xu s. FEBS Lett. 2016 Feb;590(3):408-18. doi: 10.1002/1873-3468.12069. Epub 2016 Feb 1. FEBS Lett. 2016. PMID: 26786295 Free article.

9

Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3.

Jia J, Li F, Tang XS, Xu S, Gao Y, Shi Q, Guo W, Wang X, He D, Guo P. Jia J, et al. Among authors: xu s. Oncotarget. 2016 Jun 21;7(25):37868-37881. doi: 10.18632/oncotarget.9350. Oncotarget. 2016. PMID: 27191265 Free PMC article.

10

Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.

Guan B, Wu K, Zeng J, Xu S, Mu L, Gao Y, Wang K, Ma Z, Tian J, Shi Q, Guo P, Wang X, He D, Du Y. Guan B, et al. Among authors: xu s. Oncotarget. 2017 Jan 31;8(5):8162-8172. doi: 10.18632/oncotarget.14131. Oncotarget. 2017. PMID: 28030804 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,367 results

Search Page

Filters